微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 47.18% | -6.93% | 3.89% | 81/140 | 52.37% | 健帆生物 | 78.46% | 行业排名> |
| 2025-12-31 | 45.41% | -18.81% | -8.78% | 83/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 49.78% | -21.67% | -3.7% | 75/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 51.69% | -19.74% | 1.98% | 75/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 50.69% | -12.46% | -9.37% | 70/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 55.93% | -13.46% | -12% | 64/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 63.55% | -10.26% | -1.33% | 52/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 64.41% | -8% | 11.24% | 47/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 57.9% | -17.71% | -10.4% | 61/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 64.62% | -7.56% | -8.75% | 44/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 70.82% | -4.25% | 1.16% | 24/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 70.01% | -2.86% | -0.5% | 28/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 70.36% | -5.36% | 0.65% | 26/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 69.91% | -3.36% | -5.48% | 27/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 73.96% | 2% | 2.63% | 21/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 72.06% | 2% | -0.37% | 25/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2021-12-31 | 72.34% | -6.26% | -2.7% | 30/140 | 57.98% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 74.35% | 2% | -3.66% | 25/140 | 61.5% | 三友医疗 | 90.73% | 行业排名> |
| 2020-12-31 | 77.17% | 14.02% | 14.02% | 24/140 | 60.12% | 三友医疗 | 90.5% | 行业排名> |
| 2019-12-31 | 67.68% | 0.7% | 0.7% | 43/140 | 56.96% | 三友医疗 | 90.29% | 行业排名> |
| 2018-12-31 | 67.21% | 2% | 2% | 39/140 | 56.22% | 正海生物 | 90.78% | 行业排名> |